11.9 C
New York
Saturday, October 31, 2026
- Advertisement -spot_img

TAG

Mitapivat

Mitapivat sickle cell decision moved to February 2027

The FDA extended its review of Agios mitapivat for sickle cell disease to 1 February 2027 after a safety plan response was classed as a major amendment.

Latest news

- Advertisement -spot_img